Trial intelligence / Profile preview

Newer Antidepressants with Pregabalin for Fibromyalgia

NCT02451475Phase 2Completed

Sponsor
Mansoura University
Start
Feb 2013
Primary completion
Sep 2014
Modality
Small Molecules
01

Overview

Phase 2, randomised trial of paroxetine in fibromyalgia (FM) (3 arms), sponsored by Mansoura University. Primary endpoint: Somatic Symptoms Scale-8 at 6 months. Started Feb 2013; status: completed.

02

Drugs

paroxetine
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT02451475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02451475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call